Amphastar Site 0025 — Medford, Oregon

Amphastar Site 0025 is a clinical research site located in Medford, Oregon, United States 97504.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

Amphastar Site 0025 has participated in 4 clinical trials.

Therapeutic areas: Asthma, Bronchospasm, Chronic Obstructive Pulmonary Disease (COPD).

Sponsors: Amphastar Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Medford

Browse all research sites in Oregon · View every site in Medford

• GSK Investigational Site
• Research Site
• Velocity Clinical Research Medford
• Asante Rogue Regional Medical Center
• Novartis Investigative Site
• Clinical Research Institute of Southern Oregon PC
• Providence Medford Medical Center
• Sunstone Medical Research
• Pfizer Investigational Site
• Rogue Valley Medical Center
• Velocity Clinical Research
• Duramed Investigational Site

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Amphastar Site 0025?

Amphastar Site 0025 has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Amphastar Site 0025 conducted?

Amphastar Site 0025 has 4 clinical trials on record. Their work covers Asthma, Bronchospasm, Chronic Obstructive Pulmonary Disease (COPD).

Is Amphastar Site 0025 accredited by Crixeo Clinical Trials?

Amphastar Site 0025 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Amphastar Site 0025?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.